NCR1 and neoplasm: Gaulthier et al. have shown that multifunctional antibodies called NK cell tri-specific killer engagers targeting on one side NKp46 and CD16 expressed by NK cells and on the other side tumor antigens could create a bridge in between NK cells and tumor cells facilitating natural killing [65].